| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.260 | 802 | 1.138 | 0 | 211 | 0 | 0 | 12.167 | 37.794 | 95.759 |
| Total Income - EUR | 1.260 | 802 | 1.138 | 0 | 211 | 0 | 505 | 12.167 | 37.794 | 95.761 |
| Total Expenses - EUR | 1.214 | 628 | 618 | 922 | 0 | 0 | 312 | 7.607 | 28.114 | 72.472 |
| Gross Profit/Loss - EUR | 46 | 174 | 521 | -922 | 211 | 0 | 193 | 4.559 | 9.680 | 23.290 |
| Net Profit/Loss - EUR | 8 | 150 | 205 | -922 | 204 | 0 | 178 | 4.438 | 9.328 | 20.417 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 2 |
Check the financial reports for the company - Optispecs Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.220 | 5.122 | 4.514 | 3.920 | 3.844 | 3.771 | 3.687 | 27.810 | 36.072 | 145.091 |
| Current Assets | 1.326 | 515 | 528 | 477 | 962 | 628 | 456 | 7.713 | 79.814 | 109.181 |
| Inventories | 438 | 434 | 426 | 419 | 411 | 403 | 394 | 395 | 24.943 | 58.291 |
| Receivables | 0 | 0 | 0 | 0 | 211 | 207 | 0 | 6.729 | 47.302 | 48.804 |
| Cash | 888 | 82 | 102 | 59 | 341 | 18 | 62 | 590 | 7.569 | 2.086 |
| Shareholders Funds | 478 | 623 | 818 | -119 | 88 | 86 | 263 | 4.701 | 14.015 | 34.353 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.067 | 5.014 | 4.224 | 4.516 | 4.718 | 4.312 | 3.881 | 30.822 | 61.446 | 182.327 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40.426 | 40.200 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Optispecs Med Srl